China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 1,741 | 1,929 | 1,972 | 2,602 | 4,778 |
| Cost of Goods | 1,374 | 1,375 | 1,545 | 1,351 | 1,938 |
| Gross Profit | 367 | 554 | 426 | 1,252 | 2,840 |
| Operating Expenses | 3,421 | 3,444 | 6,579 | 6,792 | 5,975 |
| Operating Income | -2,681 | -2,515 | -5,608 | -5,190 | -2,197 |
| Interest Expense | 648 | 544 | 477 | 37 | 1,615 |
| Other Income | 25 | -39 | 150 | -182 | 872 |
| Pre-tax Income | -3,304 | -3,099 | -5,935 | -5,408 | -2,941 |
| Income Tax | N/A | N/A | N/A | 328 | -193 |
| Net Income Continuous | -3,304 | -3,099 | -5,935 | -5,736 | -2,748 |
| Net Income | $-3,304 | $-3,099 | $-5,935 | $-5,736 | $-2,748 |
| EPS Basic Total Ops | -2.32 | -28.58 | -177.84 | -1,103.40 | -763.80 |
| EPS Basic Continuous Ops | -2.32 | -28.69 | -177.84 | -1,103.10 | -763.86 |
| EPS Diluted Total Ops | -2.32 | -28.58 | -177.84 | -1,103.40 | -763.80 |
| EPS Diluted Continuous Ops | -2.32 | -28.69 | -177.84 | -1,103.10 | -763.86 |
| EPS Diluted Before Non-Recurring Items | -2.32 | -28.56 | -178.00 | -1,104.00 | N/A |
| EBITDA(a) | $-2,598 | $-2,312 | $-5,357 | $-4,870 | $-1,852 |